NAME

Question types


Start with


Question limit

of 60 available terms

Advertisement Upgrade to remove ads
Print test

5 Written questions

5 Matching questions

  1. 2407.03
  2. 2410.02
  3. 2424.02
  4. 2427
  5. 2424.03
  1. a Sequence Listing Numeric Identifiers
  2. b Certification of Statement of Availability of Deposit
  3. c Failure to Replace

    37 CFR 1.805(d) sets forth the Office position that the failure to make a replacement deposit in a case pending before the Office, for example a reissue or reexamination proceeding, where a deposit is considered to be necessary to satisfy the requirements of 35 U.S.C. 112, shall cause the application or patent involved to be treated in any Office proceeding as if no deposit were made. - See more at: http://www.wikilawschool.net/wiki/MPEP_2400#sthash.r1onQWb8.dpuf
  4. d Additional Miscellaneous Requirements
  5. e Form Paragraphs and Notice to Comply

5 Multiple choice questions

  1. Description in Application Specification
    37 CFR 1.804(a)
    requirement for a specific identification consistent with the description requirement of the first paragraph of 35 U.S.C. 112 and provides an antecedent basis for the biological material which either has been or will be deposited before the patent is granted.
  2. Application in Condition for Allowance Except for Deposit

    As set forth in 37 CFR 1.809(c), in the event that an application for patent is otherwise in condition for allowance except for a required deposit and the Office has received a written assurance that an acceptable deposit will be made, applicant will be notified and given a period of time within which the deposit must be made in order to avoid abandonment of the application for failure to prosecute the application under 35 U.S.C. 133
  3. Box Sequence; Hand Delivery of Sequence Listings and Computer Readable Forms
  4. Notice to Comply
  5. Replies to Rejections Based on Deposit Issue

    Once a rejection under 35 U.S.C. 112 has been made by the examiner directed to the absence of access to a biological material, applicant may reply, pursuant to 37 CFR 1.809 (b)(1), by either making an acceptable original or replacement deposit in accordance with these regulations, or assuring the Office in writing that an acceptable deposit will be made on or before the date of payment of the issue fee, or by submitting an argument of why a deposit is not required under the circumstances of the application being considered. Other replies to such a rejection by the examiner shall be considered nonresponsive and may result in abandonment of the application. - See more at: http://www.wikilawschool.net/wiki/MPEP_2400#sthash.r1onQWb8.dpuf

5 True/False questions

  1. 2425Form and Format for Nucleotide and/or Amino Acid Sequence Submissions in Computer Readable Form

          

  2. 2409Viability of Deposit

    Viability may be tested by the depository. The test must conclude only that the deposited material is capable of reproduction. No evidence is necessarily required regarding the ability of the deposited material to perform any function described in the patent application.

          

  3. 2421Form and Format for Nucleotide and/or Amino Acid Sequence Submissions in Computer Readable Form

          

  4. 2422.04Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply

          

  5. 2426Amendments to or Replacement of Sequence Listing and Computer Readable Copy Thereof